Free Trial

ImageneBio (IMA) SEC Filings & 10K Form

ImageneBio logo
$9.14 -0.06 (-0.65%)
As of 09/12/2025 04:00 PM Eastern

Recent ImageneBio SEC Filings

DateFilerForm TypeView
08/12/2025
4:19 PM
ImageneBio (Filer)
Form 8-K/A
08/07/2025
4:26 PM
ImageneBio (Issuer)
Lu Yufang (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2025
4:29 PM
ImageneBio (Issuer)
Lu Yufang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
4:15 PM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025
3:31 PM
Deep Track Capital, LP (Filed by)
ImageneBio (Subject)
Form SCHEDULE 13G
08/01/2025
3:59 PM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
8:28 PM
ImageneBio (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
07/30/2025
8:30 PM
ImageneBio (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
8:30 PM
ImageneBio (Issuer)
Yarema Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
3:47 PM
ImageneBio (Issuer)
Stampacchia Otello (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
3:51 PM
Bonita David P (Reporting)
ImageneBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2025
8:32 PM
ImageneBio (Issuer)
Marango Jotin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2025
5:56 PM
ImageneBio (Issuer)
Yarema Kristin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2025
5:58 PM
Butler Erin (Reporting)
ImageneBio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2025
6:02 PM
Butler Erin (Reporting)
ImageneBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2025
5:04 AM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2025
1:16 PM
BML Investment Partners, L.P. (Filed by)
ImageneBio (Subject)
Form SCHEDULE 13D/A
07/25/2025
11:23 AM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2025
4:17 PM
ImageneBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2025
3:40 PM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
3:50 PM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2025
7:34 AM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2025
7:38 AM
ImageneBio (Subject)
Form 425
06/18/2025
7:23 PM
ImageneBio (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
06/16/2025
11:21 AM
BML Investment Partners, L.P. (Filed by)
ImageneBio (Subject)
Form SCHEDULE 13D
06/11/2025
11:15 PM
ImageneBio (Filer)
Form EFFECT
06/11/2025
4:08 PM
ImageneBio (Filer)
Form 424B3
06/09/2025
6:14 AM
ImageneBio (Filer)
Form S-4/A
05/30/2025
3:47 PM
ImageneBio (Filer)
Form S-4/A
05/08/2025
7:00 AM
ImageneBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
3:16 PM
ImageneBio (Filer)
Form S-4/A
04/21/2025
3:42 PM
ImageneBio (Filer)
Form S-4/A
03/18/2025
3:18 PM
ImageneBio (Filer)
Form S-4
Registration statement under Securities Act of 1933  
03/06/2025
7:30 AM
ImageneBio (Filer)
Form ARS
03/06/2025
7:10 AM
ImageneBio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
9:47 AM
BML Investment Partners, L.P. (Filed by)
ImageneBio (Subject)
Form SCHEDULE 13G/A
02/13/2025
3:22 PM
GILEAD SCIENCES, INC. (Filed by)
ImageneBio (Subject)
Form SCHEDULE 13G/A
01/10/2025
5:30 AM
ImageneBio (Subject)
Form 425
12/31/2024
2:44 PM
BML Investment Partners, L.P. (Filed by)
ImageneBio (Subject)
Form SCHEDULE 13G
12/23/2024
7:37 AM
ImageneBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
7:40 AM
ImageneBio (Subject)
Form 425
11/07/2024
7:00 AM
ImageneBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMA) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners